Management of Intrathecal Catheter‐Tip Inflammatory Masses: An Updated 2007 Consensus Statement From An Expert Panel

Background.  Expert panel of physicians and nonphysicians, all expert in intrathecal (IT) therapies, convened in the years 2000 and 2003 to make recommendations for the rational use of IT analgesics based on the preclinical and clinical literature known up to those times, presentations of the expert panel, discussions on current practice and standards, and the result of surveys of physicians using IT agents. An expert panel of physicians and convened in 2007 to review previous recommendations and to form recommendations for the rational use of IT agents as they pertain to new scientific and clinical information regarding the etiology, prevention and treatment for IT granuloma.

[1]  T. Yaksh,et al.  Time Course and Role of Morphine Dose and Concentration in Intrathecal Granuloma Formation in Dogs: A Combined Magnetic Resonance Imaging and Histopathology Investigation , 2006, Anesthesiology.

[2]  J. Spreer,et al.  Late bacterial granuloma at an intrathecal drug delivery catheter , 2006, Acta Neurochirurgica.

[3]  K. Hildebrand,et al.  A review of intrathecal fentanyl and sufentanil for the treatment of chronic pain. , 2006, Pain medicine.

[4]  J. Bailes,et al.  A review of intrathecal morphine therapy related granulomas , 2006, European journal of pain.

[5]  M. Cousins,et al.  Intrathecal catheter granuloma associated with isolated baclofen infusion. , 2006, Anesthesia and analgesia.

[6]  Rishi K Wadhwa,et al.  Spinal Cord Compression in a Patient with a Pain Pump for Failed Back Syndrome: A Chalk-Like Precipitate Mimicking a Spinal Cord Neoplasm: Case Report , 2006, Neurosurgery.

[7]  D. Shields,et al.  Extramedullary intrathecal catheter granuloma adherent to the conus medullaris presenting as cauda equina syndrome. , 2005, Anesthesiology.

[8]  R. Rosenquist,et al.  Intrathecal catheter tip inflammatory mass: a failure of clonidine to protect. , 2005, Anesthesiology.

[9]  D. Dickson.  Risks and benefits of long‐term intrathecal analgesia , 2004, Anaesthesia.

[10]  S. Hassenbusch,et al.  Polyanalgesic Consensus Conference 2003: an update on the management of pain by intraspinal drug delivery-- report of an expert panel. , 2004, Journal of pain and symptom management.

[11]  T. Deer.  A prospective analysis of intrathecal granuloma in chronic pain patients: a review of the literature and report of a surveillance study. , 2004, Pain physician.

[12]  S. Hassenbusch,et al.  Continuous intrathecal infusion of hydromorphone: safety in the sheep model and clinical implications. , 2004, Pain medicine.

[13]  C. Feler,et al.  Catheter Tip Granuloma Associated with Sacral Region Intrathecal Drug Administration , 2003, Neuromodulation : journal of the International Neuromodulation Society.

[14]  A. Panlilio,et al.  Enterobacter cloacae bloodstream infections in pediatric patients traced to a hospital pharmacy. , 2003, American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists.

[15]  K. Follett.  Intrathecal analgesia and catheter-tip inflammatory masses. , 2003, Anesthesiology.

[16]  S. Hassenbusch,et al.  Safety of Chronic Intrathecal Morphine Infusion in a Sheep Model , 2003, Anesthesiology.

[17]  C. Sommer,et al.  Chronically Infused Intrathecal Morphine in Dogs , 2003, Anesthesiology.

[18]  V. Hruby,et al.  Effects of Chronic Intrathecal Infusion of a Opioid Agonist in Dogs , 2003 .

[19]  P. Peng,et al.  Spinal Cord Compression From Intrathecal Catheter-Tip Inflammatory Mass: Case Report and a Review of Etiology , 2003, Regional anesthesia and pain medicine.

[20]  S. Hassenbusch,et al.  Inflammatory masses associated with intrathecal drug infusion: a review of preclinical evidence and human data. , 2002, Pain medicine.

[21]  S. Hassenbusch,et al.  Management of intrathecal catheter-tip inflammatory masses: a consensus statement. , 2002, Pain medicine.

[22]  R. Coffey,et al.  Inflammatory Mass Lesions Associated with Intrathecal Drug Infusion Catheters: Report and Observations on 41 Patients , 2001, Neurosurgery.

[23]  G. Racz,et al.  Intrathecal Granuloma in Patients Receiving High‐dose Intrathecal Morphine Therapy: A Report of Two Cases , 2001, Pain practice : the official journal of World Institute of Pain.

[24]  S. Hassenbusch,et al.  Current practices in intraspinal therapy--a survey of clinical trends and decision making. , 2000, Journal of pain and symptom management.

[25]  S. Hassenbusch,et al.  Evidence-based review of the literature on intrathecal delivery of pain medication. , 2000, Journal of pain and symptom management.

[26]  S. Hassenbusch,et al.  Clinical guidelines for intraspinal infusion: report of an expert panel. PolyAnalgesic Consensus Conference 2000. , 2000, Journal of pain and symptom management.

[27]  S. Hassenbusch,et al.  Future directions in the management of pain by intraspinal drug delivery. , 2000, Journal of pain and symptom management.

[28]  R. North,et al.  Neurologic Sequelae of Intraspinal Drug Delivery Systems: Results of a Survey of American Implanters of Implantable Drug Delivery Systems , 1998, Neuromodulation : journal of the International Neuromodulation Society.

[29]  P. J. Hoopes,et al.  Comparative spinal neuropathology of hydromorphone and morphine after 9- and 30-day epidural administration in sheep. , 1994, Anesthesia and analgesia.

[30]  D. Long,et al.  Spinal cord compression complicating subarachnoid infusion of morphine: case report and laboratory experience. , 1991, Neurosurgery.

[31]  Marion R McMillan,et al.  Catheter-associated masses in patients receiving intrathecal analgesic therapy. , 2003 .

[32]  Draft guidelines on quality assurance for pharmacy-prepared sterile products. , 1992, American journal of hospital pharmacy.